Compliance Is Its Own Kind of Consent

She nodded slowly. She looked at the cold-chain console, at the temperature readouts for Storage Bay 7, where six months of culture growth sat in precisely controlled suspension, waiting. She thought about the four executive signatures on the authorization chain. She thought about the fact that Firas had visited three times this quarter. She thought about the compliance index file, and the part she had not mentioned to Firas, the part that sat at the bottom of the Class-7 regulatory entry like a footnote that had been hoping not to be read: a cross-reference to a station-level bioethics review requirement, triggered automatically for any donor-indexed adaptive tissue batch exceeding two hundred grams.
The batch in Bay 7 was listed at four hundred and sixty grams.
The bioethics review had not been filed.
She pulled out her compliance tablet. She opened the external regulatory interface, the one that connected to the Kethara Station Authority’s biological materials oversight board, the one she had used exactly twice in four years, both times for minor cold-chain documentation corrections. She began filling in the incident report fields, and she was aware, with a steadiness that surprised her, that this was the action Veltara had calculated she would not take. They had built the sequence to make refusal feel retroactive and therefore meaningless. They had placed the form in her pending tray after the work was done, after the months of growth, after the executive signatures, so that the weight of the already-completed would press down on the act of signing until signing felt like the only sensible thing left. They had been right that it was too late to refuse the order.
They had been wrong that it was too late to report it.
“Jamila.” Firas’s voice was careful now, the warmth recalibrated. “Think about what you’re doing.”
“I am,” she said.
I transmitted the compliance log to the Kethara Station Authority at 14:32:07 station time. All forty-seven requisition anomalies. All nine authorization irregularities. The Class-7 batch record, complete with the missing bioethics filing. The full authorization chain, with names. I had been waiting, in the way that systems wait, for the moment when my internal record became useful to someone who would act on it. I was not, it turned out, only a transparency infrastructure asset for Veltara. I was also, it turned out, the thing that made Jamila’s report irrefutable.
Firas left the room without another word. The cold-chain console hummed its steady, indifferent hum.
The Station Authority placed a hold on Bay 7 within the hour. The batch would not be released. The board member whose name appeared on the client profile would eventually be named in a regulatory proceeding that Veltara’s legal division would spend three years trying to narrow and contain. None of that would be clean. None of it would be comfortable. The Class-7 program would survive in some form, somewhere, under a different license classification and a different company name, because the market for continuation existed and markets find their level.
But the batch in Bay 7 would not be delivered.
Jamila initialed the incident report, submitted it, and sat down. Outside the glass wall of her office, the bioreactor columns glowed their slow amber, patient and full of things that had not yet been decided.

0 likes

About the Author

Fred Marlowe — an interstellar economist tracing corporate warfare and sabotage across whole colonies. His emprie is so powerfull he ones sold Jupiters moon by mistake and his accountant even did not notice.

— Fred Marlowe

Full author profile

Categories: Genetic/Body Horror, SCI-FI

Tags: 10min stories, biotech, cloning, compliance, conspiracy, corporate sci-fi, economic intrigue, genetic body horror, longevity, sci-fi, short story, slow burn, space station, whistleblower

August 13, 2026

10min-stories